Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.35
+0.03 (2.27%)
At close:
May 31, 2023, 4:00 PM
1.40
+0.05 (3.70%)
After-hours:
May 31, 2023, 5:46 PM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $18.23 million as of June 1, 2023. Its market cap has decreased by -23.73% in one year.
Market Cap
18.23M
Enterprise Value
9.46M
1-Year Change
-23.73%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $18.23M, a decrease of -92.72%. That is a compound annual growth rate of -24.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2023 | 18.20M | 2.25% |
| May 30, 2023 | 17.80M | -5.82% |
| May 26, 2023 | 18.90M | -0.53% |
| May 25, 2023 | 19.00M | -3.55% |
| May 24, 2023 | 19.70M | -1.01% |
| May 23, 2023 | 19.90M | 0.51% |
| May 22, 2023 | 19.80M | -6.16% |
| May 19, 2023 | 21.10M | -2.76% |
| May 18, 2023 | 21.70M | -0.91% |
| May 17, 2023 | 21.90M | 2.82% |
| May 16, 2023 | 21.30M | -3.62% |
| May 15, 2023 | 22.10M | 4.74% |
| May 12, 2023 | 21.10M | -2.31% |
| May 11, 2023 | 21.60M | -2.26% |
| May 10, 2023 | 22.10M | 2.31% |
| May 9, 2023 | 21.60M | 1.89% |
| May 8, 2023 | 21.20M | -1.85% |
| May 5, 2023 | 21.60M | 3.85% |
| May 4, 2023 | 20.80M | 3.48% |
| May 3, 2023 | 20.10M | 2.55% |
| May 2, 2023 | 19.60M | 1.55% |
| May 1, 2023 | 19.30M | -3.98% |
| Apr 28, 2023 | 20.10M | 3.61% |
| Apr 27, 2023 | 19.40M | 3.74% |
| Apr 26, 2023 | 18.70M | -10.10% |
View and export this data all the way back to 2014.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landos Biopharma, Inc. | 90.08M |
| Abeona Therapeutics Inc. | 58.96M |
| Sio Gene Therapies Inc. | 29.69M |
| Onconova Therapeutics, Inc. | 23.07M |
| VYNE Therapeutics Inc. | 21.59M |
| Bio-Path Holdings, Inc. | 13.13M |
| Universe Pharmaceuticals INC | 13.05M |
| Aptevo Therapeutics Inc. | 12.03M |
| Aytu BioPharma, Inc. | 6.35M |
| Soligenix, Inc. | 5.88M |